Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bradding (Leicester (Leicestershire), United Kingdom). Mast cells in lung disease: clinical implications. International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications

Member's Comments

No comment yet.

Related content which might interest you: Mast cells in lung disease Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Oral presentation: Human lung parenchyma cells: a potential therapeutic cell source for lung disease Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Mast cells in asthma: biomarker and therapeutic target Source: Eur Respir J 2016; 47: 1040-1042 Year: 2016 Mesenchymal stromal cells in clinical trials: implications for emphysema Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017 T-cell biology and eosinophils in asthma: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Mast cells in human airways: the culprit? Source: Eur Respir Rev 2014; 23: 299-307 Year: 2014 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease Source: International Congress 2016 – ILD pathogenesis Year: 2016 Angiogenic T cells in interstitial lung diseases Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010 Current perspectives in epithelial cell injury and repair: consequences for epithelial functions Source: Eur Respir Rev 2005; 14: 126-130 Year: 2005